Evolent Health (EVH) Income towards Parent Company (2014 - 2026)

Evolent Health's Income towards Parent Company history runs 13 years deep, the most recent figure standing at -$26.6 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 58.82% year-over-year to -$26.6 million; the TTM figure through Mar 2026 stood at -$496.5 million (down 355.52% YoY), while the FY2025 annual figure was -$534.5 million, changed N/A from the prior year.
• Income towards Parent Company was -$26.6 million for Q1 2026 at Evolent Health, up from -$429.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $1.6 million in Q2 2024 to a low of -$429.1 million in Q4 2025.
• Historically, Income towards Parent Company has averaged -$58.5 million across 5 years, with a median of -$20.9 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Income towards Parent Company tumbled 1781.23% in 2025, then surged 58.82% in 2026.
• A 5-year view of Income towards Parent Company shows it stood at -$463000.0 in 2022, then sank by 4213.39% to -$20.0 million in 2023, then retreated by 14.22% to -$22.8 million in 2024, then sank by 1781.23% to -$429.1 million in 2025, then surged by 93.8% to -$26.6 million in 2026.
• The last three Income towards Parent Company figures came in at -$26.6 million (Q1 2026), -$429.1 million (Q4 2025), and -$20.9 million (Q3 2025), per Business Quant data.